Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mario Maldonado-Lutomirsky"'
Autor:
Bente Vangen, Eirik Søfteland, Juris J. Meier, Uli C. Broedl, Robert Toorawa, Mario Maldonado-Lutomirsky
Publikováno v:
Diabetes Care. 40:201-209
OBJECTIVE To evaluate the efficacy and safety of empagliflozin versus placebo as add-on therapy in patients with type 2 diabetes and inadequate glycemic control with linagliptin and metformin. RESEARCH DESIGN AND METHODS Patients with HbA1c ≥8.0% a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de7bf8464f044aaf1590525071f8dce
https://doi.org/10.2337/dc16-1347
https://doi.org/10.2337/dc16-1347
Autor:
Uli C. Broedl, Sophia Götz, Hans-Juergen Woerle, Matias Nordaby, Francisco J. Tinahones, Baptist Gallwitz, Mario Maldonado-Lutomirsky
Publikováno v:
Diabetes, obesitymetabolism. 19(2)
Aim To evaluate the efficacy and safety of linagliptin versus placebo as add-on to empagliflozin and metformin in patients with type 2 diabetes. Materials and methods Patients with inadequate glycaemic control despite stable-dose metformin received o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fea0263ae5f2804a9c1c4ff42dfb777
https://pubmed.ncbi.nlm.nih.gov/27762093
https://pubmed.ncbi.nlm.nih.gov/27762093
Autor:
Francisco Tinahones, Baptist Gallwitz, Matias Nordaby, Sophia Götz None, Mario Maldonado-Lutomirsky
Publikováno v:
Endocrine Practice. 22:76-77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bee20d853d3a8a1b0b1e26154657a93
https://doi.org/10.1016/s1530-891x(20)44994-8
https://doi.org/10.1016/s1530-891x(20)44994-8
Publikováno v:
Gastrointestinal Endoscopy. 45:199-204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae5767fb9901b8d949b76ecd1689563
https://doi.org/10.1016/s0016-5107(97)70252-9
https://doi.org/10.1016/s0016-5107(97)70252-9